E
Enanta Pharmaceuticals, Inc.
ENTA · NASDAQ · Healthcare · 383M
Price · close
$13.47
+2.59% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
4.4×
Enterprise value / EBITDAEV/EBITDA
-6.4×
Free cash flow yieldFCF yield
-11.2%
Return on equityROE
-126.5%
Operating margin
-130.7%
Net debt / EBITDAbalance-sheet strength
-2.4×
Interest coverage
-11.1×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.